BIIB
BIOGEN INC.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$240.98
−0.87%Forward multiples
Based on analyst estimates
- P/E forward
- 15.71x
- P/E 2026E
- 19.41x
- P/E 2027E
- 14.59x
- P/E 2028E
- 12.93x
- P/S forward
- 3.37x
Trailing multiples
Trailing twelve months
- P/E TTM
- 42.43x
- PEG TTM
- 0.25x
- Price / book
- 1.89x
- Price / sales
- 3.58x
- Price / cash flow
- 12.37x
Enterprise value
- Enterprise value
- $42.7B
- EV / sales
- 4.29x
- EV / EBITDA
- 21.82x
- EV / EBIT
- 33.54x
- Market cap
- $35.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026